Your browser doesn't support javascript.
loading
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.
George, Sonia; Tyson, Trevor; Rey, Nolwen L; Sheridan, Rachael; Peelaerts, Wouter; Becker, Katelyn; Schulz, Emily; Meyerdirk, Lindsay; Burmeister, Amanda R; von Linstow, Christian U; Steiner, Jennifer A; Galvis, Martha L Escobar; Ma, Jiyan; Pospisilik, J Andrew; Labrie, Viviane; Brundin, Lena; Brundin, Patrik.
Affiliation
  • George S; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Tyson T; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Rey NL; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Sheridan R; Laboratory of Neurodegenerative Diseases, Institut François Jacob, MIRCen, CEA, CNRS, Fontenay-aux-Roses, France.
  • Peelaerts W; Flow Cytometry Core Facility, Van Andel Institute, Grand Rapids, MI, USA.
  • Becker K; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Schulz E; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Meyerdirk L; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Burmeister AR; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • von Linstow CU; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Steiner JA; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Galvis MLE; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Ma J; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Pospisilik JA; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Labrie V; Center for Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.
  • Brundin L; Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.
  • Brundin P; Michigan State University - College of Human Medicine, Department of Psychiatry, Grand Rapids, MI, USA.
J Parkinsons Dis ; 11(2): 585-603, 2021.
Article in En | MEDLINE | ID: mdl-33579871
ABSTRACT

BACKGROUND:

α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson's disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, as well as the activation of T and B cells. These immune changes point towards a dysregulation of both the innate and the adaptive immune system. T cells have been shown to recognize epitopes derived from α-syn and altered populations of T cells have been found in PD and MSA patients, providing evidence that these cells can be key to the pathogenesis of the disease.ObjectiveTo study the role of the adaptive immune system with respect to α-syn pathology.

METHODS:

We injected human α-syn preformed fibrils (PFFs) into the striatum of immunocompromised mice (NSG) and assessed accumulation of phosphorylated α-syn pathology, proteinase K-resistant α-syn pathology and microgliosis in the striatum, substantia nigra and frontal cortex. We also assessed the impact of adoptive transfer of naïve T and B cells into PFF-injected immunocompromised mice.

RESULTS:

Compared to wildtype mice, NSG mice had an 8-fold increase in phosphorylated α-syn pathology in the substantia nigra. Reconstituting the T cell population decreased the accumulation of phosphorylated α-syn pathology and resulted in persistent microgliosis in the striatum when compared to non-transplanted mice.

CONCLUSION:

Our work provides evidence that T cells play a role in the pathogenesis of experimental α-synucleinopathy.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Synucleinopathies Limits: Animals / Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Synucleinopathies Limits: Animals / Humans Language: En Year: 2021 Type: Article